Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCL2 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | CXADR | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | RCAN1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | SLAMF9 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | CYSLTR2 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
mRNA | ZBTB20 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | NAE1 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
mRNA | PXMP4 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | CCDC159 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | KIAA1644 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |